Impaired Glucose Tolerance and Neuropathy
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Peripheral neuropathy is common. Diabetes is the most common cause, accounting for approximately half of cases, but up to 1/3rd of neuropathy patients have no identifiable etiology. Among this population, impaired glucose tolerance (IGT or "prediabetes") is observed in approximately 40%. The exact nature of the relationship between IGT and neuropathy is debated. REVIEW SUMMARY: A variety of evidence suggests IGT causes neuropathy. Neuropathy may occur early in diabetes. The neuropathy associated with IGT is clinically similar to early diabetic neuropathy, with preferential injury to small nerve fibers resulting in pain and autonomic dysfunction. IGT and diabetic neuropathy patients share abnormal microvascular endothelial dysfunction. Treatment of IGT subjects with diet and exercise reduces risk of progression to diabetes, and those with neuropathy experience a short-term improvement in small fiber function with sustained benefit for pain. An evolving literature links other aspects of the metabolic syndrome to peripheral neuropathy. CONCLUSIONS: IGT is common in peripheral neuropathy patients. The extent to which IGT directly causes nerve injury as opposed to being a covariant with other equally or more important features (eg, obesity, metabolic syndrome) remains to be determined. Preliminary data suggest diet and exercise counseling may be a useful treatment strategy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Symptoms manifest as neuropathic pain and/or loss of sensation that, coupled with poor blood flow, increase the risk of foot injuries and ulcerations ( 45 , 244 ).”
From Exercise and Type 2 Diabetes (2010) · cites this paper as [244]
In the citing paper
“Hyperglycemia causes nerve toxicity, leading to nerve damage and apoptosis ( 242 , 244 ), which causes microvascular damage and loss of perfusion.”
From Exercise and Type 2 Diabetes (2010) · cites this paper as [244]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 2×
“Over 3 years, 30% of the placebo group progressed to diabetes and 25% reverted to normoglycemia.(7) Although the severity of glucose dysregulation worsened over time, 45% remained classified as IGT.”
BackgroundResultTuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“23%).(32) These studies established diet and exercise as the standard of therapy for IGT.”
BackgroundReport of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378 · cited 1×
“Those in the multifactorial arm were significantly less likely to develop coronary, cerebral or peripheral vascular occlusive disease, nephropathy, retinopathy or autonomic neuropathy.(41) TABLE 1.”
BackgroundThe global burden of headache: A documentation of headache prevalence and disability worldwide
Stovner, L., Hagen, K., Jensen, R., Katsarava, Z., Lipton, R., Scher, A., Steiner, T., & Zwart, J.-A. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01288.x · Cited by 2,444
Glucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371
Lewis, G. F., Carpentier, A., Adeli, K., & Giacca, A. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.2.0461 · Cited by 1,333
Vascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population
Cowie, C. C., Rust, K. F., Byrd-Holt, D. D., Eberhardt, M. S., Flegal, K. M., Engelgau, M. M., Saydah, S. H., Williams, D. E., Geiss, L. S., & Gregg, E. W. (2006) · Diabetes Care · doi:10.2337/dc06-0062 · Cited by 1,210 · cited 1×
“An additional 3% have undiagnosed diabetes.(4) An estimated 26% of Americans have IFG,(4) and other population-based estimates indicate 11% to 14% have IGT.”
Background
Research works printed but not linked: 2
- Singleton, 2007, Diet and exercise counseling alone does not prevent long-term neuropathy progression in IGTN., Neurology, 68, A410
- Rose, 2006, Increased prevalence of metabolic syndrome in peripheral neuropathy., Neurology, 65, 103
Cited by
Colberg, S. R., Sigal, R. J., Fernhall, B., Regensteiner, J. G., Blissmer, B. J., Rubin, R. R., Chasan-Taber, L., Albright, A. L., & Braun, B. (2010) · Diabetes Care · doi:10.2337/dc10-9990 · Cited by 1,955
“Hyperglycemia causes nerve toxicity, leading to nerve damage and apoptosis (242,244), which causes microvascular damage and loss of perfusion.”
Schalkwijk, C. G., & Stehouwer, C. D. A. (2020) · Physiological Reviews · doi:10.1152/physrev.00001.2019 · Cited by 622
Pre-Diabetes, Metabolic Syndrome, and Cardiovascular Risk
Grundy, S. M. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.080 · Cited by 627
Diabetic neuropathy: cellular mechanisms as therapeutic targets
Vincent, A. M., Callaghan, B. C., Smith, A. L., & Feldman, E. L. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.137 · Cited by 566
Self-citation(2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181eeb61c · Cited by 567
Metadata
- Authors
- Smith, A. G., & Singleton, J. R.
- Affiliations
- University of Utah (US)
- Corresponding author
- Smith, A Gordon
- Singleton, J Robinson
- Venue
- The Neurologist
- Published
- 2008-01
- Volume
- 14
- Issue
- 1
- Pages
- 23-29
- ISSN
- 1074-7931 (ISSN-L)
- OpenAlex
- W2039399774
- Cited by
- 165
- References
- 46
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 3 · 2023: 5 · 2022: 6 · 2021: 5 · 2020: 3 · 2019: 11 · 2018: 6 · 2017: 9 · 2016: 9 · 2015: 10 · 2014: 12 · 2013: 8 · 2012: 18
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Neurologist (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Center for Research Resources (M01RR000064, M01RR0064)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- impaired glucose tolerance, prediabetes, peripheral neuropathy, diabetic neuropathy, small fiber neuropathy, autonomic dysfunction, neuropathic pain, endothelial dysfunction, metabolic syndrome, obesity, diet and exercise intervention, progression to diabetes
- MeSH terms
- Diabetic Neuropathies, Glucose, Humans, Microcirculation, Peripheral Nervous System Diseases, Peripheral Nerves, Disease Progression, Metabolic Syndrome, Nerve Fibers, Unmyelinated, Risk Reduction Behavior
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impaired Glucose Tolerance and Neuropathy. https://app.cochat.ai/papers/10.1097/nrl.0b013e31815a3956
- The paper
- Smith, A. G., & Singleton, J. R. (2008). Impaired Glucose Tolerance and Neuropathy. The Neurologist. https://doi.org/10.1097/nrl.0b013e31815a3956
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.